Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021

We describe the development of a risk assessment profile tool that incorporates data from multiple domains to help determine activities and events where rapid antigen detection tests (Ag-RDT) could be used to screen asymptomatic individuals to identify infectious cases as an additional mitigation me...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Euro surveillance : bulletin européen sur les maladies transmissibles 2022-01, Vol.27 (3), p.1
Hauptverfasser:	Mallon, Patrick Wg, Horgan, Mary, McAloon, Conor G, Lunn, Peter D, Little, Julian, Beck, Andrew, Bennett, Alexandria, Shaver, Nicole, Conway, Aileen, O'Regan, Rhea, Whelan, Barbara
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Antigens Antigens, Viral COVID-19 COVID-19 diagnostic tests Disease transmission Health risk assessment Humans Ireland Rapid Communication Risk Assessment SARS-CoV-2 Sensitivity and Specificity Severe acute respiratory syndrome coronavirus 2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We describe the development of a risk assessment profile tool that incorporates data from multiple domains to help determine activities and events where rapid antigen detection tests (Ag-RDT) could be used to screen asymptomatic individuals to identify infectious cases as an additional mitigation measure to reduce transmission of SARS-CoV-2. The tool aims to stratify, in real time, the overall risk of SARS-CoV-2 transmission associated with common activities and events, and this can be matched to an appropriate Ag-RDT testing protocol.
ISSN:	1560-7917 1025-496X 1560-7917
DOI:	10.2807/1560-7917.ES.2022.27.3.2101202